US Capital Global Increases Financing for the US Healthcare Industry during the COVID-19 Pandemic

San Francisco-based private financial group experiences rising demand for customized and scalable alternative financing solutions from enterprises serving the US healthcare industry.

Owning and operating a business in the healthcare industry can be highly rewarding. Nevertheless, healthcare is also an industry that can come with larger overheads and requires significantly higher levels of capital expenditure. Structuring and securing the right debt or equity business financing is therefore essential.

Providing Custom Financing for Healthcare Companies

US Capital Global’s healthcare finance team understands the industry and the challenges owners and CFOs face. The firm has deep experience in financing businesses across a wide range of healthcare sub-industries, including medical devices and equipment, pharmaceuticals, biotechnology, medical facilities and services, and drug manufacturing.

“US Capital Global has a reputation for being an innovator in the healthcare financing space,” said Jeffrey Sweeney, Chairman and CEO at US Capital Global. “Over the past 36 months, the firm has already facilitated or provided over $150 million in financing for lower middle market businesses that serve the US healthcare industry. Our finance professionals understand the challenges and opportunities in the industry, and can design a healthcare financing solution that fits the specific needs of your business.”

Example Transactions

Click on the tombstones below for further details about these selected transactions.

Disclaimer: Advisory services offered by US Capital Global refer exclusively to broker-lender advisory services for companies, and do not include any registered investment advisory.

To learn more about how your business can secure the funding it needs, email Jeffrey Sweeney, Chairman and CEO, at jsweeney@uscapglobal.com or call (415) 889-1010

---

Download a PDF of this Press Release